Concepedia

Kevin M. Nash

KM

Statistics

Publications

15

Citations

704

H-Index

13

Active since

2010

Affiliations

The Ohio State University(Current)

University of Toledo

Health and Functional Exposomics

Lung Institute

Kevin M. Nash is an author at The Ohio State University specializing in medicinal chemistry, pharmacology, and drug discovery.

ORCID

Publications per year

2010–2021

15

Publications

15

Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors

Anthony A. Estrada, Xingrong Liu, Charles Baker‐Glenn et al. · Journal of Medicinal Chemistry · 2012 · 164 citations · Full text

, , +17

Discovery of Highly Potent, Selective, and Brain-Penetrant Aminopyrazole Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors

Anthony A. Estrada, Bryan Chan, Charles Baker‐Glenn et al. · Journal of Medicinal Chemistry · 2013 · 126 citations · Full text

, , +17

Reactive Nitrogen Species Reactivities with Nitrones: Theoretical and Experimental Studies

Kevin M. Nash, Antal Rockenbauer, Frederick A. Villamena · Chemical Research in Toxicology · 2012 · 63 citations · Full text

, , +15

Fast Reactivity of a Cyclic Nitrone−Calix[4]pyrrole Conjugate with Superoxide Radical Anion: Theoretical and Experimental Studies

Shang-U Kim, Yangping Liu, Kevin M. Nash et al. · Journal of the American Chemical Society · 2010 · 53 citations

, , +13

Discovery of a Highly Selective, Brain-Penetrant Aminopyrazole LRRK2 Inhibitor

Bryan Chan, Anthony A. Estrada, Huifen Chen et al. · ACS Medicinal Chemistry Letters · 2012 · 44 citations · Full text

, , +15

1–5 of 15